Discover
VYGR
Voyager Therapeutics, Inc.
3.60
2 x 2.52
2 x 4.46
bid
ask
+
0.10
2.86%
2 @ 04:00 PM
3.51 -0.09 (2.50%)
| Ytd | -8.40% | |
| 1y | 12.50% |
3.44
day range
3.61
2.88
52 week range
5.55
| Open | 3.50 | Prev Close | 3.50 | Low | 3.44 | High | 3.61 | Mkt Cap | 217.52M |
| Vol | 538.66K | Avg Vol | 570.66K | EPS | -1.98 | P/E | N/A | Forward P/E | -3.41 |
| Beta | 0.89 | Short Ratio | 4.44 | Inst. Own | 65.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.74 | 200-d Avg | 4.07 | 1yr Est | 17.10 |
VYGR News
benzinga.com
Jim Cramer: TE Connectivity Is ‘Terrific,’ Buy This Industrial Stock
Jim Cramer recommended buying GE Vernova Inc. as Bernstein analyst initiated coverage with an Outper
globenewswire.com
Voyager's Tau-Targeted Gene Therapy VY1706 for Alzheimer's Disease to Be Featured in Developing Topi
LEXINGTON, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a bio
benzinga.com
Voyager Therapeutics Issued FDA Clearance For Its Investigational New Drug Application For VY1706 To
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics